people getting covid and they do not have, say, diabetes or co morbidities. for example, if someone gets the disease, we are giving not only people leaving. to see if that will protect the people from getting the vaccine. that will roll out in a few months. >> a prophylactic for people who are near folks with covid. last question here. how many of these pills can you produce, how quickly? when will we see the market full of these? >> i think right now, because of the investments we did, you remember back in the summer i said i had approved already a billion dollars, it was 1.2 of risk investment. that was mainly oriented to manufacturing. we expect to have 500 million